• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EncephalApp斯特鲁普测试在巴西用于筛查轻微肝性脑病的验证。

EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil.

作者信息

Cunha-Silva Marlone, Neto Fernando L Ponte, de Araújo Priscila S, Pazinato Lucas V, Greca Raquel D, Secundo Tirzah M L, Imbrizi Marcello R, Monici Leonardo T, Sevá-Pereira Tiago, Mazo Daniel F

机构信息

Division of Gastroenterology (Gastrocentro), University of Campinas (Unicamp), Campinas, Brazil.

Division of Gastroenterology (Gastrocentro), University of Campinas (Unicamp), Campinas, Brazil.

出版信息

Ann Hepatol. 2022 Jan-Feb;27(1):100543. doi: 10.1016/j.aohep.2021.100543. Epub 2021 Sep 24.

DOI:10.1016/j.aohep.2021.100543
PMID:34571266
Abstract

INTRODUCTION AND OBJECTIVES

The EncephalApp Stroop Test was developed to more easily diagnose minimal hepatic encephalopathy (MHE). A cut-off of >274.9sec (ONtime+OFFtime) reached a 78% sensitivity and 90% specificity in the validation study, but it has been poorly studied in Brazil. We aim to analyze the usefulness of this diagnostic method and to describe a cut-off value to screen MHE in Brazil.

METHODS

In this cross-sectional and single-center study, three positive psychometric tests defined the diagnosis of MHE as the gold standard. We evaluated gender, age, education, familiarity with smartphones, etiology of cirrhosis, Child-Pugh/MELD scores, and previous hepatic encephalopathy (HE). Healthy controls and patients without HE were compared for the task validation. The Chi-square and Mann-Whitney tests, logistic regression analysis, and ROC curves were used for statistical evaluation.

RESULTS

We included 132 patients with cirrhosis (61% male) and 42 controls (62% male) around 51y. Sixty-three were diagnosed with MHE on psychometric tests and 23 had clinical HE. Viral hepatitis (38%) was the major etiology of cirrhosis. The median MELD was 10 and Child-Pugh A was more frequent (70%). There was no significant difference in test results between controls and patients without HE. There was also no influence of gender, age, education, and familiarity with smartphones in the test results. Child-Pugh A was associated with MHE (p=0.0106). A cut-off of >269.8sec (ONtime+OFFtime) had an 87% sensitivity and 77% specificity to detect MHE (p=0.002).

CONCLUSION

This is a valid and reliable tool for screening MHE. However, optimal cut-off values need to be validated locally.

摘要

引言与目的

开发EncephalApp斯特鲁普测试是为了更轻松地诊断轻微肝性脑病(MHE)。在验证研究中,>274.9秒(开启时间+关闭时间)的临界值达到了78%的灵敏度和90%的特异性,但在巴西对其研究较少。我们旨在分析这种诊断方法的实用性,并描述巴西用于筛查MHE的临界值。

方法

在这项横断面单中心研究中,三项阳性心理测量测试将MHE的诊断定义为金标准。我们评估了性别、年龄、教育程度、对智能手机的熟悉程度、肝硬化病因、Child-Pugh/MELD评分以及既往肝性脑病(HE)情况。将健康对照者和无HE的患者进行任务验证比较。采用卡方检验、曼-惠特尼检验、逻辑回归分析和ROC曲线进行统计评估。

结果

我们纳入了约51岁左右的132例肝硬化患者(61%为男性)和42例对照者(62%为男性)。63例经心理测量测试诊断为MHE,23例有临床HE。病毒性肝炎(38%)是肝硬化的主要病因。MELD中位数为10,Child-Pugh A级更为常见(70%)。对照者和无HE的患者之间测试结果无显著差异。性别﹑年龄、教育程度和对智能手机的熟悉程度对测试结果也无影响。Child-Pugh A级与MHE相关(p=0.0106)。>269.8秒(开启时间+关闭时间) 的临界值检测MHE的灵敏度为87%,特异性为77%(p=0.002)。

结论

这是一种筛查MHE的有效且可靠的工具。然而,最佳临界值需要在当地进行验证。

相似文献

1
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil.EncephalApp斯特鲁普测试在巴西用于筛查轻微肝性脑病的验证。
Ann Hepatol. 2022 Jan-Feb;27(1):100543. doi: 10.1016/j.aohep.2021.100543. Epub 2021 Sep 24.
2
The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.Stroop 智能手机应用程序是一种简短有效的方法,用于筛查轻微肝性脑病。
Hepatology. 2013 Sep;58(3):1122-32. doi: 10.1002/hep.26309. Epub 2013 May 23.
3
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.验证 EncephalApp_Stroop 作为一种筛查工具,用于检测德国肝硬化患者的轻微肝性脑病。
Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101873. doi: 10.1016/j.clinre.2022.101873. Epub 2022 Feb 3.
4
EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis.EncephalApp Stroop 应用程序预测乙型肝炎引起的肝硬化导致的轻微肝性脑病患者睡眠质量差。
Saudi J Gastroenterol. 2020 May-Jun;26(3):120-128. doi: 10.4103/sjg.SJG_558_19.
5
Validation of EncephalApp Stroop Test for Diagnosing Minimal Hepatic Encephalopathy in the Romanian Population.《罗马尼亚人群中 EncephalApp 斯特鲁普测试诊断轻微型肝性脑病的验证》
J Gastrointestin Liver Dis. 2024 Sep 29;33(3):355-361. doi: 10.15403/jgld-5231.
6
Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.EncephalApp 斯特鲁普测试在评估肝硬化患者隐匿性肝性脑病中的表现。
Acta Med Indones. 2023 Jul;55(3):296-306.
7
EncephalApp stroop test versus electronic number connection test-A for screening minimal hepatic encephalopathy in patients with liver cirrhosis: a comparative study.EncephalApp 斯特鲁普测验与电子数字连接测验 A 用于肝硬化患者轻微肝性脑病的筛查:一项比较研究。
Scand J Gastroenterol. 2022 Sep;57(9):1066-1069. doi: 10.1080/00365521.2022.2055975. Epub 2022 Mar 29.
8
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.基于智能手机的Stroop测试EncephalApp用于隐匿性肝性脑病诊断的验证
Clin Gastroenterol Hepatol. 2015 Oct;13(10):1828-1835.e1. doi: 10.1016/j.cgh.2014.05.011. Epub 2014 May 17.
9
Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.使用Stroop脑病应用程序诊断轻微肝性脑病:一项基于美国多中心的、基于常模的研究。
Am J Gastroenterol. 2016 Jan;111(1):78-86. doi: 10.1038/ajg.2015.377. Epub 2015 Dec 8.
10
[Impact of different diagnostic criteria for assessing mild micro-hepatic encephalopathy in liver cirrhosis: an analysis based on a prospective, multicenter, real-world study].[不同诊断标准对评估肝硬化轻度微肝性脑病的影响:一项基于前瞻性、多中心、真实世界研究的分析]
Zhonghua Gan Zang Bing Za Zhi. 2023 Sep 20;31(9):961-968. doi: 10.3760/cma.j.cn501113-20220602-00298.

引用本文的文献

1
Minimal hepatic encephalopathy: Characteristics and comparison of the main diagnostic modalities.轻微肝性脑病:主要诊断方法的特点及比较
Clin Exp Hepatol. 2024 Dec;10(4):218-226. doi: 10.5114/ceh.2024.145438. Epub 2024 Dec 2.
2
Innovative diagnostic tool aids screening for minimal hepatic encephalopathy in non-alcoholic cirrhosis patients.创新诊断工具助力非酒精性肝硬化患者轻微肝性脑病的筛查。
World J Hepatol. 2025 Jan 27;17(1):101420. doi: 10.4254/wjh.v17.i1.101420.
3
Acute effects of moderate-intensity continuous physical exercise performed with different amounts of muscle mass on executive function in healthy young adults: a randomized trial.
不同肌肉量参与的中等强度持续体育锻炼对健康年轻成年人执行功能的急性影响:一项随机试验。
EXCLI J. 2023 Sep 25;22:1032-1046. doi: 10.17179/excli2023-6434. eCollection 2023.
4
Assessment of Minimal Hepatic Encephalopathy with Brain MRI and EncephalApp Stroop Test.使用脑部磁共振成像和EncephalApp斯特鲁普测验评估轻微肝性脑病
Maedica (Bucur). 2023 Mar;18(1):4-11. doi: 10.26574/maedica.2023.18.1.4.
5
A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.一种缩短版 Stroop 测试,用于识别肝硬化患者的隐匿性肝性脑病并预测显性肝性脑病。
J Gastroenterol. 2022 Dec;57(12):981-989. doi: 10.1007/s00535-022-01925-0. Epub 2022 Sep 29.
6
Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy.失代偿期肝硬化患者的粪便微生物群移植:安全性和有效性的系统评价
Antibiotics (Basel). 2022 Jun 23;11(7):838. doi: 10.3390/antibiotics11070838.
7
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.粪便微生物群移植治疗肝硬化患者肝性脑病和艰难梭菌感染疗效及安全性的系统评价
Cureus. 2022 May 31;14(5):e25537. doi: 10.7759/cureus.25537. eCollection 2022 May.